Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence

Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the ongoing COVID-19 (coronavirus disease-2019) outbreak and has unprecedentedly impacted the public health and economic sector. The pandemic has forced researchers to focus on the accurate and early detection of SARS-CoV-2, develop...

Full description

Bibliographic Details
Main Authors: Elda A. Flores-Contreras, Reyna Berenice González-González, Iram P. Rodríguez-Sánchez, Juan F. Yee-de León, Hafiz M. N. Iqbal, Everardo González-González
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biosensors
Subjects:
SARS-CoV-2
COVID-19
microfluidic
chip
biosensors
diagnostics
Online Access:https://www.mdpi.com/2079-6374/12/3/179

Internet

https://www.mdpi.com/2079-6374/12/3/179

Similar Items